Return to fertility in nulliparous and parous women after removal of the GyneFix<sup>®</sup>intrauterine contraceptive system

Delbarge, W.; Batar, I; Bafort, M.; Bonnivert, J.; Colmant, C.; Dhont, Marc; Fonzé, V.; Gevers, R.; Janssens, Dirk; Lavalley, Ph.; Salmin, E.; Degueldre, Michel; Vrijens, M.; Kets, H. Van; Wildemeersch, Dirk

doi:10.1080/ejc.7.1.24.30

Cited by 17 publications

(5 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In aggregate conception rates at 12 months following discontinuation of cyclic OCs (21 days of active hormone pills followed by 7 days of placebo pills) in women wishing to conceive range from 72%-94% (1, 2, 17, 22-25; Table 1). In comparison, published 12-month conception rates are 75%-79% in women stopping the levonorgestrel (LNG) IUD (26)(27)(28) and 71% to 92% in women stopping the copper IUD (28)(29)(30)(31)(32)(33)(34) in order to conceive.…”

Section: Return To Fertility Following Discontinuation Of Cyclic Oralmentioning

confidence: 99%

See 1 more Smart Citation

Return to fertility following discontinuation of oral contraceptives

Barnhart

Schreiber

2009

Fertility and Sterility

View full text Add to dashboard Cite

Section: Return To Fertility Following Discontinuation Of Cyclic Oralmentioning

confidence: 99%

“…The figure provides the range of 12-month conception rates reported in women stopping various methods of contraception (1,2,17,(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)49). OC, oral contraceptive; Cu, copper; IUD, intrauterine device; LNG, levonorgestrel; DMPA, depot medroxyprogestrone acetate; POP, progesterone-only pill.…”

Section: Figurementioning

confidence: 99%

Return to fertility following discontinuation of oral contraceptives

Barnhart

Schreiber

2009

Fertility and Sterility

View full text Add to dashboard Cite

“…The force of traction (expressed in Newtons) required for removing the GyneFix 1 , measured with a special dynamometer, averages 6.1-6.2 N 9 . GyneFix 1 does not affect adversely future fertility 10 .…”

Section: Flexible Devicesmentioning

confidence: 95%

State-of-the-art of intrauterine contraception

Batar

2006

The European Journal of Contraception & Reproductive Health

View full text Add to dashboard Cite

Despite its nearly 100-year history, intrauterine contraception is a modern method even in the 21st century and its development is still going on. The aim of innovations is to optimize the contraceptive efficacy and to suppress as much as possible side effects and unwanted events (e.g. menstrual irregularities, expulsion). It is important that this method be made available to all those who could not resort to it earlier (young women, nulligravidae, nulliparae). Currently three areas are more particularly being investigated: (1) flexible, frameless intrauterine implants, (2) levonorgestrel-releasing intrauterine systems, and (3) metal alloy intrauterine devices. Partly relying on the author's own clinical experience and based on the literature of recent years, this article reviews the present state and possibilities with regard to further development of intrauterine contraceptive devices.

show abstract

“…76 Nevertheless, it showed to be an effective reversible method of contraception with a net cumulative pregnancy rate of 88% at 12 months and 99% after 2 years of observation. 77 Moreover, the design characteristics of the frameless IUD (fixed, frameless, and flexible) are responsible for the low expulsion, high effectiveness, and high continuation rates. 78,79 Frameless systems under development.…”

Section: New Developments In Intrauterine Contraceptionmentioning

confidence: 99%

Contraception Today

Benagiano

Bastianelli

Farris

2006

Annals of the New York Academy of Sciences

View full text Add to dashboard Cite

Modern contraceptive methods represent more than a technical advance: they are the instrument of a true social revolution-the "first reproductive revolution" in the history of humanity, an achievement of the second part of the 20th century, when modern, effective methods became available. Today a great diversity of techniques have been made available and-thanks to them, fertility rates have decreased from 5.1 in 1950 to 3.7 in 1990. As a consequence, the growth of human population that had more than tripled, from 1.8 to more than 6 billion in just one century, is today being brought under control. At the turn of the millennium, all over the world, more than 600 million married women are using contraception, with nearly 500 million in developing countries. Among married women, contraceptive use rose in all but two developing countries surveyed more than once since 1990. Among unmarried, sexually active women, it grew in 21 of 25 countries recently surveyed. Hormonal contraception, the best known method, first made available as a daily pill, can today be administered through seven different routes: intramuscularly, intranasally, intrauterus, intravaginally, orally, subcutaneously, and transdermally. In the field of oral contraception, new strategies include further dose reduction, the synthesis of new active molecules, and new administration schedules. A new minipill (progestin-only preparation) containing desogestrel has been recently marketed in a number of countries and is capable of consistently inhibiting ovulation in most women. New contraceptive rings to be inserted in the vagina offer a novel approach by providing a sustained release of steroids and low failure rates. The transdermal route for delivering contraceptive steroids is now established via a contraceptive patch, a spray, or a gel. The intramuscular route has also seen new products with the marketing of improved monthly injectable preparations containing an estrogen and a progestin. After the first device capable of delivering progesterone directly into the uterus was withdrawn, a new system releasing locally 20 microg evonorgestrel is today marketed in a majority of countries with excellent contraceptive and therapeutic performance. Finally, several subcutaneously implanted systems have been developed: contraceptive "rods," where the polymeric matrix is mixed with the steroid and "capsules" made of a hollow polymer tube filled with free steroid crystals. New advances have also been made in nonhormonal intrauterine contraception with the development of "frameless" devices. The HIV/AIDS pandemic forced policy makers to look for ways to protect young people from sexually transmitted diseases as well as from untimely pregnancies. This led to the development of the so-called dual protection method, involving the use of a physical barrier (condom) as well as that of a second, highly effective contraceptive method. More complex is the situation with antifertility vaccines, still at a preliminary stage of development and unlikely to be in widespread use f...

show abstract

Return to fertility in nulliparous and parous women after removal of the GyneFix^®intrauterine contraceptive system

Cited by 17 publications

References 1 publication

Return to fertility following discontinuation of oral contraceptives

Return to fertility following discontinuation of oral contraceptives

State-of-the-art of intrauterine contraception

Contraception Today

Contact Info

Product

Resources

About

Return to fertility in nulliparous and parous women after removal of the GyneFix®intrauterine contraceptive system

Cited by 17 publications

References 1 publication

Return to fertility following discontinuation of oral contraceptives

Return to fertility following discontinuation of oral contraceptives

State-of-the-art of intrauterine contraception

Contraception Today

Contact Info

Product

Resources

About

Return to fertility in nulliparous and parous women after removal of the GyneFix^®intrauterine contraceptive system